Compounded ketotifen topical cream or gel prepared per prescriber direction for individualized dermatologic allergy or mast cell-related care planning. Prescription required.
Ketotifen Topical Cream or Gel is a compounded dermatologic preparation created by HDRx according to individualized prescriber specifications. A valid prescription from a licensed healthcare provider is required.
Ketotifen is described in pharmacology literature as an antiallergic medication with antihistamine activity and mast cell–stabilizing properties. These mechanisms are discussed in clinical contexts involving immune responses, hypersensitivity reactions, and mast cell activity.
Compounded topical preparations allow healthcare providers to request customized strengths and delivery bases, such as creams or gels, depending on the specific needs of an individualized care plan. This flexibility supports targeted application to localized areas when prescribers determine it is appropriate.
Ketotifen has been referenced in research and clinical discussions involving allergic conditions and mast cell–related responses, particularly when providers are evaluating individualized approaches for complex hypersensitivity or inflammatory skin presentations.
To learn more about ketotifen and mast cell stabilization, visit our ketotifen compounding page, explore our article on compounded ketotifen and mast cell activation syndrome, and read about mast cell stabilizers used in compounding pharmacy practice.
Compounded medications are not FDA-approved and are prepared to meet specific patient needs as directed by a licensed healthcare provider. Patients should consult their prescriber to determine whether this formulation is appropriate for their individual care plan.
